هكذا تنظر الدكتورة Jewel Kling في قسم صحة المرأة في Mayo Clinic عن علاج النساء اللاتي يعانين من أعراض انقطاع الطمث مثل الهبات الساخنة والتعرق الليلي. هناك العديد من العلاجات غير الهرمونية التي تبدأ من الأساليب العقلية الجسدية إلى الدواء، والتي يمكنها التخفيف من الآلام مع وجود القليل من الآثار الجانبية أو بدونها.
A new program seeks to improve community oncology providers’ knowledge of genetic testing in breast cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.
For women with breast cancer who opt for breast reconstruction using a tissue flap from the abdomen, gene testing for high-risk mutations should be performed before surgery, concludes a report in the July issue of Plastic and Reconstructive Surgery®
The Rutgers School of Public Health is excited to announce that Slawa Rokicki, PhD, will be joining the department of health behavior, society, and policy as an instructor in August.
Obesity during pregnancy may negatively affect children’s lung development, according to new research. The study, published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology, was chosen as an APSselect article for July.
Today, Sigma Chi International Fraternity announced a new $20-million pledge to Huntsman Cancer Foundation (HCF), dedicated to and used for women’s cancer research, treatment and wellness at Huntsman Cancer Institute (HCI). The announcement came during the fraternity’s biennial Grand Chapter conference in Salt Lake City. This pledge follows an $11 million pledge made in 2015, the largest to date in the history of men’s fraternities.
Dr. Beth Karlan, the newly appointed director of cancer population genetics at UCLA’s Jonsson Comprehensive Cancer Center, is hopeful that her research will not only help women get diagnosed with ovarian cancer at an earlier stage, but also identify the women who are most at-risk so they can intervene before the cancer even develops.
Despite similar rates of infertility among all socioeconomic groups, white women, women with higher education levels, and women with higher incomes are at least twice as likely to seek treatment as other groups of women, new research suggests.
Dra. Jewel Kling de la División de Salud Femenina de Mayo Clinic analiza el tratamiento de las mujeres con síntomas de menopausia, como sofocos y sudores nocturnos. A fin de aliviar los síntomas con pocos efectos secundarios o ninguno, existen muchas terapias sin hormonas, que varían desde técnicas de mente y cuerpo hasta medicamentos.
Lindsay Bowerman was sitting at her kitchen table preparing to take her sons to their swim lessons when she felt a “snap” in her head that was immediately followed by intense pressure and the worst pain she had ever experienced. The healthy 36-year-old woman had just suffered a ruptured brain aneurysm.
Study will focus on four previously identified regions in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
Mothers-to-be now have a new option when it comes to their prenatal care and birth of their babies. Wake Forest Baptist Health today revealed a two-floor, state-of-the-art labor and delivery center and a leading-edge neonatal intensive care unit (NICU) on its Winston-Salem campus.
Mayo Clinic has received a combined gift of $5 million from Penny and Bill George, and the George Family Foundation, to create the innovative Center for Women's Health. The center will be a destination where women will receive personalized, holistic health care that is tailored to meet their needs throughout their lives.
Researchers at the University of Michigan Rogel Cancer Center and U-M College of Engineering have found that breast cancer cells that swallow up nearby stem cells take on some of their properties, enhancing their ability to invade other tissues throughout the body and seed secondary tumors, a process known as metastasis.
A new supplement to the peer-reviewed journal Women’s Health Issues, sponsored by the Cooperative Studies Program of the Veterans Health Administration (VA) Office of Research and Development, examines sex and gender differences in U.S. veterans’ health conditions and responses to treatments.
Women exposed to triclosan are more likely to develop osteoporosis, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
NCCN Oncology Research Program (ORP) issues request for proposals to improve quality of care for people with stage III, stage IV, and recurrent epithelial ovarian cancer.
Mayo Clinic will host the Sixth Annual Metastatic Breast Cancer Conference at the Omni Scottsdale Resort and Spa at Montelucia in Scottsdale, Arizona, Sept. 19–20. This program is a joint effort among Mayo Clinic, Baylor College of Medicine, and Theresa's Research Foundation.
Investigators at Rutgers Cancer Institute of New Jersey have developed a computational method that uncovers clinically relevant gene expression patterns in large cohorts of breast cancer patients. This method, which is applicable to the analysis of all cancers, can robustly describe molecular processes that are associated with tumor subtypes and can identify predictive markers of response to treatment or disease recurrence.
Mayo Clinic Children's Center has again been ranked as one of the top-performing children's hospitals in Iowa, Minnesota, North Dakota and South Dakota on U.S. News & World Report's 2019–2020 "Best Children's Hospitals" rankings.
Duke researchers describe a previously unidentified route for antibodies to be transferred from the mother to the fetus, illuminating a potential way to capitalize on this process to control when and how certain antibodies are shared.
Nearly $165,000 was raised at the Women’s Heart Fund Annual Reception held on May 31 at the Bay Head Yacht Club in Bay Head, NJ. Co-chaired by Mollie Giamanco, who is also a board member for the Hackensack Meridian Health Bayshore Medical Center Foundation, and Lisa Loshiavo, 275 guests attended the fundraiser, which will support the Center for Survivorship and Wellness Care located at Hackensack Meridian Health Jersey Shore University Medical Center’s HOPE Tower. The evening featured a cocktail-style format, an array of hors d’oeuvres and stations, music, dancing, a 50/50 raffle and the Ultimate Golf Raffle, which awarded 27 winners with a round of golf at one of 27 premiere golf courses. Additionally, Denise McKnight, a cancer survivor and patient who had all of her treatments inside HOPE Tower, offered remarks about her experience and what the center will mean to other survivors.
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.
Intermountain Healthcare and deCODE genetics have announced a major global collaboration and study focused on discovering new connections between genetics and human disease that will involve the collection of half a million DNA samples.
There is no amount, pattern or timing of alcohol use during pregnancy proven safe for a developing fetus. Repeat: there is no amount, pattern or timing of alcohol use during pregnancy proven safe for a developing fetus. Drinking in pregnancy can have a range of harmful consequences for the child ─ including poor growth, learning and behavioral difficulties, problems with movement and co-ordination, and distinctive facial features ─ that are collectively known as fetal alcohol spectrum disorders (FASD). Screening for alcohol use during pregnancy is a necessary first step in preventing FASD, but studies have suggested that primary care providers do not screen consistently and can be hesitant to follow up with women who report drinking. New research published in the journal Alcoholism: Clinical & Experimental Research has evaluated midwives’ and nurse-midwives’ understanding of the risks of drinking in pregnancy, and their screening practice.
Sleeping with a television or light on in a room may be a risk factor for gaining weight or developing obesity, according to scientists at the National Institutes of Health. The research, published online June 10 in JAMA Internal Medicine, suggests that cutting off lights at bedtime could reduce women’s chances of becoming obese.
An unhealthy, inflamed gut causes breast cancer to become much more invasive and spread more quickly to other parts of the body, new research from the University of Virginia Cancer Center suggests.
The foods and nutrients a woman consumes while pregnant have important health implications for her and her baby. Nutrition 2019, the annual meeting of the American Society for Nutrition, will feature new research on prenatal vitamins, infant supplements and the impacts of a mother’s diet during pregnancy and after the baby is born.
تشير الدراسات إلى أن خطر الإصابة بسرطان الثدي يمكن أن ينخفض إلى النصف من خلال استخدام دورة مدتها خمس سنوات من تاموكسيفين أو رالوكسيفين، وأيضًا عن طريق مثبطات الأروماتاز. ومع ذلك، فإن النساء المعرضات للإصابة بسرطان الثدي بدرجة كبيرة تنخفض لديهن نسبة قبول العلاج الوقائي.
A University at Buffalo-led research team has used public narratives, an increasingly popular form of person-centered advocacy offering a forum for sharing previously untold stories, to study the undue stress experienced by women in relation to abortion.
Estudos mostram que o risco de câncer de mama pode ser reduzido pela metade com o uso de tamoxifeno e raloxifeno no transcorrer de cinco anos, e também de inibidores de aromatase. No entanto, mulheres com alto risco de desenvolver câncer de mama têm baixa aceitação da medicina preventiva.
Novos estudos sobre a detecção precoce do câncer colorretal e o impacto da terapia celular na qualidade de vida estão entre as várias apresentações da Mayo Clinic no encontro anual da Sociedade Americana de Oncologia Clínica em Chicago.
Athletes invest hours practicing before a big game. Runners train for months leading up to a marathon. A mother-to-be should likewise prepare herself for the mental and physical rigor of pregnancy, labor and caring for a newborn.
Los estudios muestran que la administración durante 5 años de tamoxifeno, raloxifeno e incluso de los inhibidores de la aromatasa puede reducir a la mitad el riesgo de cáncer de mama. Sin embargo, las mujeres con alto riesgo de cáncer de mama se muestran renuentes a aceptar este medicamento preventivo.
“Individualized therapies are strongly recommended and the treatment decision should be made collaboratively with a multidisciplinary team consisting of obstetricians, gynecologists, oncologists, pediatricians, and psychologists,” says researcher.
Results of a phase 3 clinical trial by researchers at UCLA’s Jonsson Comprehensive Cancer Center found that women with HER2-positive breast cancer had significantly better response rates, but more severe side effects, when they were treated with traditional neoadjuvant chemotherapy along with dual HER2-targeted blockade, compared to a more novel approach using HER2-targeted chemotherapy plus HER2-targeted blockade.
The Henry Ford Cancer Institute has earned a full three-year accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program of the American College of Surgeons. Henry Ford Hospital, Henry Ford Macomb Hospital and Henry Ford West Bloomfield Hospital each earned full re-accreditation, along with new accreditation for Henry Ford Wyandotte Hospital and Henry Ford Allegiance Health, meaning each hospital program within Henry Ford Cancer Institute is now fully-accredited.
Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene, and also by aromatase inhibitors. Nevertheless, women at high risk of breast cancer have a low acceptance of preventive medicine.
A new study by Mayo Clinic and collaborators at the University of Manitoba and CancerCare Manitoba suggests that when women at high risk are presented with personalized genetic information, they're more likely to take preventative medications to reduce their chance of developing breast cancer. The research involved a new blood test developed by Mayo Clinic to identify women at higher genetic risk for developing breast cancer.
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
More than 20 physicians and researchers from Seattle Cancer Care Alliance (SCCA) will present at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL May 31 – June 4, 2019.
BRCA, the DNA-repair protein family, interacts with a multipart, molecular complex that is also responsible for regulating the immune system. When certain players in this pathway go awry, autoimmune disorders, like lupus, can arise. Researchers have now deciphered the structure of the complex and have found new molecular targets for fighting autoimmunity.
A first of its kind study is reporting that millions of women in low- and middle-income countries will need life-saving radiotherapy to treat their cervical cancer, despite the growth of essential human papilloma virus (HPV) vaccination prevention programs.
There are stark differences in the information provided and conversations doctors have with women and men about elective sterilization. Iowa State researchers analyze the influence of gender and how doctors and patients can improve these conversations.
Researchers at The Johns Hopkins University and other institutions report that a new laboratory test that induces cancer cells to squeeze through narrow spaces has the potential to accurately predict which breast cancers and other solid tumors are likely to spread, or metastasize, to other sites. The test, they say, might also help clinicians select the best drugs to prevent cancer’s spread.
New research by School of Nursing professor Sheila Ridner finds that a special scan measuring lymphatic fluid volume is significantly better than a tape measure at predicting which women undergoing treatment for breast cancer are at risk of developing a common complication resulting from damaged lymph nodes.